Recruiting Lung Cancer Studies in Hamilton
ATATcH Alternating Treatment Plans for Advanced Cancer
The purpose of the research is to evaluate a new schedule of alternating cycles of induction chemoimmunotherapy (chemotherapy plus pembrolizumab) and immunotherapy (pembrolizumab) alone for the initia...
Testing Experimental Anti-cancer Drug SLC-391 with an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers
SLC-391 is a novel, potent and specific small molecule inhibitor of receptor tyrosine kinase AXL with desirable potency and pharmaceutical properties. The study is being done to evaluate the safety a...
About Lung Cancer Clinical Trials in Hamilton
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Hamilton, NJ. These studies are seeking a combined 242 participants. Research is being sponsored by Rutgers, The State University of New Jersey, SignalChem Lifesciences Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Hamilton — FAQ
Are there lung cancer clinical trials in Hamilton?
Yes, there are 2 lung cancer clinical trials currently recruiting in Hamilton, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hamilton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hamilton research site will contact you about next steps.
Are clinical trials in Hamilton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hamilton studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Hamilton are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov